Endoscope Reprocessing and Endoscopic Probe Disinfection Market Size, Share and Growth Outlook, 2026

Endoscope Reprocessing and Endoscopic Probe Disinfection Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Endoscope Reprocessing and Endoscopic Probe Disinfection Market size is forecast to increase from $3.05 Billion in 2026 to $6.12 Billion in 2034 at a CAGR of 9.1% between 2026 and 2034.

The Endoscope Reprocessing and Endoscopic Probe Disinfection market report provides detailed analysis and outlook of Endoscope Reprocessing and Endoscopic Probe Disinfection segments including By Product Type (Automated Endoscope Reprocessors, High-Level Disinfectants, Detergents, Enzymatic Cleaners, & Wipes, Endoscope Drying, Storage, & Transport Cabinets, Reprocessing Accessories, Endoscope Tracking & Digital Documentation Solutions), By Modality (Flexible Endoscope Reprocessing, Rigid Endoscope Reprocessing, Robot-Assisted Endoscope Reprocessing, Ultrasound Transducer ), By Clinical Application (Gastrointestinal, Pulmonology & Bronchoscopy, Urology & Gynecology, ENT, Otolaryngology, & Laparoscopy, Cardiology ), By End-User (Hospitals & Central Sterile Supply Departments, Ambulatory Surgical Centers, Specialized Outpatient Clinics & Diagnostic Imaging Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Endoscope Reprocessing and Endoscopic Probe Disinfection Industry Overview

Advanced High-Level Disinfection Technologies Reshaping Infection Prevention Workflows

The endoscope reprocessing and endoscopic probe disinfection industry is undergoing significant transformation as healthcare providers prioritize infection prevention, regulatory compliance, and automated disinfection technologies. Rising concerns regarding healthcare-associated infections and cross-contamination risks are accelerating the adoption of advanced high-level disinfection systems for semi-critical medical devices. Hospitals, diagnostic imaging centers, and outpatient facilities are increasingly investing in automated ultraviolet disinfection platforms, digital traceability systems, and validated decontamination workflows to improve patient safety and strengthen quality assurance programs.

Automated UV-C Disinfection Systems Enhancing Clinical Efficiency

A major trend in the market is the deployment of automated ultraviolet disinfection technologies for ultrasound and endoscopic probes. Natus Medical Incorporated completed infrastructure upgrades across its diagnostic hospital networks by integrating advanced automated ultrasound probe disinfection stations into routine clinical workflows. These systems replace traditional manual chemical wipe methods with high-intensity UV-C automated enclosures capable of delivering multi-layered microbial destruction within a rapid 60-second cycle. The technology is specifically designed for transesophageal and transvaginal ultrasound probes, enabling faster turnaround times while ensuring standardized and repeatable disinfection outcomes. Growing adoption of automated UV-C systems reflects the healthcare sector’s emphasis on reducing human error and improving operational efficiency.

Digital Traceability Platforms Strengthening Compliance and Documentation

Healthcare facilities are increasingly implementing digital monitoring tools to ensure complete traceability throughout the disinfection process. Nanosonics Limited enhanced its Nanosonics AuditPro platform with automated traceability capabilities that directly connect patient records with the disinfection history of specific ultrasound probes and flexible endoscopes. The system records critical information including chemical concentration levels, exposure cycles, and operator identification details. By integrating device reprocessing data with patient documentation, healthcare providers can strengthen accreditation compliance, improve audit readiness, and maintain comprehensive infection control records.

Regulatory Requirements Accelerating Automated Disinfection Adoption

Regulatory agencies continue to drive modernization within the endoscopic probe disinfection industry. Updated guidance issued by the U.S. FDA in collaboration with The Joint Commission requires all semi-critical reusable devices, including ultrasound transducers and flexible endoscopes, to undergo verified automated high-level disinfection or complete chemical sterilization between patient uses. The guidance specifically eliminates reliance on manual immersion bucket methods, reinforcing the importance of validated automated processing systems. These evolving regulatory requirements are increasing demand for advanced disinfection technologies, automated documentation solutions, and standardized reprocessing protocols across healthcare facilities.

Endoscope Reprocessing and Endoscopic Probe Disinfection Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Endoscope Reprocessing and Endoscopic Probe Disinfection market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- STERIS plc, Getinge AB, Olympus Corporation, Ecolab Inc. (Advanced Sterilization Products), Cantel Medical (STERIS), Borer Chemie AG, Medivators (Cantel/STERIS), Olympus Corporation, Serim Research Corporation, MDD Company GmbH. The Endoscope Reprocessing and Endoscopic Probe Disinfection market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Endoscope Reprocessing and Endoscopic Probe Disinfection industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Endoscope Reprocessing and Endoscopic Probe Disinfection Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Endoscope Reprocessing and Endoscopic Probe Disinfection companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Endoscope Reprocessing and Endoscopic Probe Disinfection markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Endoscope Reprocessing and Endoscopic Probe Disinfection Market Competitive Benchmarking and Company Analysis

Leading companies in Endoscope Reprocessing and Endoscopic Probe Disinfection industry include- STERIS plc, Getinge AB, Olympus Corporation, Ecolab Inc. (Advanced Sterilization Products), Cantel Medical (STERIS), Borer Chemie AG, Medivators (Cantel/STERIS), Olympus Corporation, Serim Research Corporation, MDD Company GmbH. The Endoscope Reprocessing and Endoscopic Probe Disinfection market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Endoscope Reprocessing and Endoscopic Probe Disinfection Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Endoscope Reprocessing and Endoscopic Probe Disinfection market remains one of the strongest-performing segments in the country.
The US Endoscope Reprocessing and Endoscopic Probe Disinfection Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Endoscope Reprocessing and Endoscopic Probe Disinfection market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Endoscope Reprocessing and Endoscopic Probe Disinfection industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Endoscope Reprocessing and Endoscopic Probe Disinfection markets

Canada's strong Endoscope Reprocessing and Endoscopic Probe Disinfection sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Endoscope Reprocessing and Endoscopic Probe Disinfection market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Endoscope Reprocessing and Endoscopic Probe Disinfection Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Endoscope Reprocessing and Endoscopic Probe Disinfection market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Endoscope Reprocessing and Endoscopic Probe Disinfection population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Endoscope Reprocessing and Endoscopic Probe Disinfection industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Endoscope Reprocessing and Endoscopic Probe Disinfection market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Endoscope Reprocessing and Endoscopic Probe Disinfection sales through 2034

France Endoscope Reprocessing and Endoscopic Probe Disinfection companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Endoscope Reprocessing and Endoscopic Probe Disinfection Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Endoscope Reprocessing and Endoscopic Probe Disinfection distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Endoscope Reprocessing and Endoscopic Probe Disinfection Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Endoscope Reprocessing and Endoscopic Probe Disinfection market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Endoscope Reprocessing and Endoscopic Probe Disinfection industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Endoscope Reprocessing and Endoscopic Probe Disinfection industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Endoscope Reprocessing and Endoscopic Probe Disinfection Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Endoscope Reprocessing and Endoscopic Probe Disinfection market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Endoscope Reprocessing and Endoscopic Probe Disinfection market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Endoscope Reprocessing and Endoscopic Probe Disinfection Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Endoscope Reprocessing and Endoscopic Probe Disinfection Market Segmentation

By Product Type
Automated Endoscope Reprocessors
High-Level Disinfectants
Detergents, Enzymatic Cleaners, & Wipes
Endoscope Drying, Storage, & Transport Cabinets
Reprocessing Accessories
Endoscope Tracking & Digital Documentation Solutions
By Modality
Flexible Endoscope Reprocessing
Rigid Endoscope Reprocessing
Robot-Assisted Endoscope Reprocessing
Ultrasound Transducer
By Clinical Application
Gastrointestinal
Pulmonology & Bronchoscopy
Urology & Gynecology
ENT, Otolaryngology, & Laparoscopy
Cardiology
By End-User
Hospitals & Central Sterile Supply Departments
Ambulatory Surgical Centers
Specialized Outpatient Clinics & Diagnostic Imaging Centers

Top Companies in Endoscope Reprocessing and Endoscopic Probe Disinfection Industry

STERIS plc
Getinge AB
Olympus Corporation
Ecolab Inc. (Advanced Sterilization Products)
Cantel Medical (STERIS)
Borer Chemie AG
Medivators (Cantel/STERIS)
Olympus Corporation
Serim Research Corporation
MDD Company GmbH

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Biotech and Fermented Ingredient Integration to gain rapid penetration

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025